Health Care & Life Sciences » Pharmaceuticals | Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 137.27 M
Public Float
 105.61 M
Ionis Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $2.48
Market Cap
 $9.06 B
Shares Outstanding
 140.32 M
Public Float
 124.9 M
Ionis Pharmaceuticals Inc.
Stock Exchange SIX Swiss Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 137.27 M
Public Float
 105.61 M

Profile

Address
2855 Gazelle Court
Carlsbad California 92010
United States
Employees -
Website http://www.ionispharm.com
Updated 07/08/2019
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs.

Financials

View All
Created with Highcharts 5.0.14Ionis Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.60 64460 64438 98438 98488 27888 27886 55686 5569 6619 661276 868276 868201320142015201620172018050k100k150k200k250k300k
Created with Highcharts 5.0.14Ionis Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.147 285147 285214 161214 161283 703283 703346 620346 620507 666507 666599 674599 6742013201420152016201720180100k200k300k400k500k600k700k

Stanley T. Crooke
Chairman, President & Chief Executive Officer
B. Lynne Parshall
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.